Latisse
The U.S. Food and Drug Administration (FDA) has approved Latisse (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. Latisse is a once-daily prescription treatment...
Consumer Information (Drugs.com) · More like this · Add to my drug list

Latisse Solution
Latisse is used for: Increasing the length, thickness, and darkness of eyelashes.
Consumer Information (MedFacts) · More like this

Latisse

Advanced Consumer Information (Micromedex) · More like this · Add to my drug list

Latisse
LATISSE™ (bimatoprost ophthalmic solution) 0.03% is a synthetic prostaglandin analog. Its chemical name is (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-- 1-pentenyl]cyclopentyl]-5-N-ethylheptenamide,- and its molecular weight is 415.58. Its molecular formula is C25H37NO4....
Professional Monographs (FDA) · More like this · Add to my drug list

Bimatoprost
Bimatoprost Pronunciation: (bye-MAT-oh-prost) Class: Prostaglandin agonist Trade Names: Latisse - Solution, ophthalmic 0.03% Trade Names: Lumigan - Solution, ophthalmic 0.03% Pharmacology Latisse Mechanism of action in treating hypotrichosis...
A-Z Drug Facts (Facts & Comparisons) · More like this · Add to my drug list

See also: Eyelash Hypotrichosis

Having trouble finding what you want?

• Try browsing our A-Z List of Drug Names or our Medical Encyclopedia.
• Try posting your query on the Drugs.com Community Discussion Boards
• Drug Interactions Checker provides detailed information on drug-drug and drug-food interactions.
• Pill Identifier will help you identify an unknown pill by imprint code or shape/color.
• Image Search is helpful if you want to know what a certain pill looks like.
• News, FDA Approvals or In The Pipeline may help if the drug you are looking for is a new drug.